Loss of hypoglycemia awareness in an adolescent with type 1 diabetes mellitus during treatment with fluoxetine hydrochloride

Journal of Pediatrics

Volumn 136, Issue 3, 2000, Pages 394-396

  Sawka, Anna M ^a   Burgart, Virginia ^a   Zimmerman, Donald ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ADOLESCENT; ARTICLE; AWARENESS; CASE REPORT; DEPRESSION; DIAPHORESIS; GLUCOSE BLOOD LEVEL; HUMAN; HUNGER; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL;

EID: 0033913029     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.103851     Document Type: Article

References (12)

1. 1. De Vane CL, Sallee FR. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: review of published experience. J Clin Psychiatry 1996;57:55-66.
2. 2. Goodnick PJ, Henry JH, Buki VMV. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995;56:128-36.
3. 3. Stokes PE, Holtz A. Fluoxetine tenth anniversary update: the progress continues. Clin Ther 1997;19:1135-250.
4. 4. Mitrakou CR, Veneman T, Jenssen T, Kiss I, Durrant J, Cryer P, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991;260:E67-74.
5. 5. Mokan M, Mitrakou A, Thiemo V, Ryan C, Korytkowski M, Cryer P, et al. Hypoglycemia unawareness in IDDM. Diabetes Care 1994;17:1397-403.
6. 6. Connolly VM, Gallagher A, Kesson CM. A study of fluoxetine in obese elderly patients with type 2 diabetes. Diabet Med 1995;12:416-8.
7. 7. Goldstein DJ, Rampey AH Jr, Evans GG, Potvin JH, Fludzinski LA, Levine LR. Fluoxetine: a randomized clinical trial in the treatment of obesity. Int J Obes 1994;18:129-35.
8. 8. Wilson GA, Furman BL. Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycemia in mice. Eur J Pharmacol 1982;78:263-70.
9. 9. Thompson CJ, Jones IR, Walker M, Baylis PH, Kendall-Taylor P. The effects of the specific serotonin antagonist ICI 169, 369 on pituitary hormone response to insulin-induced hypoglycemia in humans. Clin Endocrinol 1992;36:235-40.
10. 2 receptor antagonists on insulin-induced adrenomedullary catecholamine release. Neuroenclocrinology 1991;54:639-45.
11. 11. Gillman PK. Serotonin syndrome: history and risk. Fundam Clin Pharmacol 1998;2:482-91.
12. 12. Cook EH Jr, Metz J, Leventhal BL, Lebovitz M, Nathan M, Semerdjian SA, et al. Fluoxetine effects on cerebral glucose metabolism. Neuroreport 1994;5:1745-8.